About Zolex Therapeutics

About company

Zolex Therapeutics focuses on the development of new classes of orally-active antibiotics to combat life-threatening bacterial infections. It is a recently established drug company focusing on the development of new classes of orally-active, small molecular weight antibiotics that target Staphylococcus aureus (Staph. A), including Methicillin Resistant Staphylococcus aureus (MRSA) strains.